Gregory Beatty June 9, 2022 Cancer, Pancreatic cancer Historical controls for trials in pancreatic cancer Gregory Beatty June 9, 2022 Cancer, Pancreatic cancer What are the right historical controls for Phase II studies in 1L metastatic pancreatic cancer?
Gregory Beatty June 5, 2022 Immunotherapy, Blog, Cancer Biomarkers for CD40 immunotherapy Gregory Beatty June 5, 2022 Immunotherapy, Blog, Cancer The neutrophil to lymphocyte ratio is a prognostic biomarker of CD40 immunotherapy.